TransCode Therapeutics, Inc. (RNAZ)
10.08
+1.45
(+16.80%)
USD |
NASDAQ |
Dec 11, 15:04
TransCode Therapeutics Cash from Investing (Quarterly): 0.00 for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 401.00M |
| Eli Lilly & Co. | -2.983B |
| Aquestive Therapeutics, Inc. | -0.235M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.083M |
| Cash from Financing (Quarterly) | -0.4557M |
| Free Cash Flow | -14.52M |
| Free Cash Flow Per Share (Quarterly) | -4.898 |
| Free Cash Flow to Equity (Quarterly) | -4.083M |
| Free Cash Flow to Firm (Quarterly) | -4.077M |
| Free Cash Flow Yield | -307.1% |